Navigation Links
Emerging class of therapeutics represents a coming wave for developers and manufacturers
Date:1/22/2014

After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.

Ann M. Thayer, senior correspondent at C&EN, explains that ADCs are essentially molecular missiles. They are made up of a toxic payload (a drug) attached to an antibody that specifically seeks out sick cells, such as tumor cells. They don't release their lethal cargo until they reach their target. The advantages of this approach are clear: It spares healthy cells and lowers drug side effects. It can also extend the life of a drug under an expiring patent or salvage an antibody that was ineffective by itself. ADCs hold a lot of promise. Of the two approved ADCs, one is soon expected to be a blockbuster. About 30 more are in clinical trials with another 100 or more ADCs in the preclinical pipeline. Projections show that by 2018, sales of ADCs could top $5 billion.

On the manufacturing side, because these drugs are so complex, suppliers are still figuring out how to streamline production. At the moment, ADCs are a niche area of manufacturing with only a few contract manufacturing organizations able to put all the pieces together from start to finish. But many are responding and investing millions to expand capacity for this promising new class.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. UF researchers look for ways to make an emerging technology safe for environment
2. Updates in Interventional Radiology accents emerging trends, practice growth
3. DNA Sequencing: Emerging Technologies and Applications
4. Malaysia to battle nutrition transition problem emerging worldwide: More income, poorer diet choices
5. Scientists question the designation of some emerging diseases
6. Emerging virus in raccoons may provide cancer clues
7. Nanoparticle researcher will inaugurate prestigious emerging leaders lecture series
8. Press registration open for ASM Biodefense and Emerging Diseases Research Meeting
9. Young malaria parasites refuse to take their medicine, may explain emerging drug resistance
10. Watering the forest for the trees emerging as priority for forest management
11. Emerging importance of computerized cognitive testing -- new therapies for dementia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... ... October 04, 2018 , ... ... University of Illinois Extension and Monroe County Economic Development Corporation (EDC), has ... Institute of Food and Agriculture (NIFA) Non-Land Grant College of Agriculture (NLGCA) ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation ... diabetes and progressive diabetic kidney disease in a four-site, pan-European Phase I/II ...
(Date:10/2/2018)... , ... October 02, 2018 , ... ... cancer research laboratory, ACEA Biosciences, The Cell Analysis Company , is excited ... specifically for immuno-oncology applications. Experimental design and data analysis for immune oncology researchers ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... Pa. (PRWEB) , ... October 04, 2018 , ... ... a new brand identity and website that elevates the company’s brand identity and ... EARTHRES, the company offers a broader range of engineering expertise and related support ...
(Date:10/2/2018)... (PRWEB) , ... October 02, 2018 , ... ... and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen for ... Oil and Gulf Energy Information, honor leading innovations in upstream oil applications that ...
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx ... early-stage companies to access the power of influence analytics and data-driven engagement decision ... a broader market that didn’t necessarily have access to the same financial resources ...
(Date:9/27/2018)... ROCHELLE, Va. (PRWEB) , ... September 26, 2018 ... ... announced today that Dr. B. Melina Cimler, a senior quality, regulatory, and in ... life science and FDA-regulated global diagnostic industry has joined the firm as an ...
Breaking Biology Technology: